维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Simmons BA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	GM CSF as a systemic adjuvant in a phase Ⅱ prostate cancer vaccine trial 显示文摘	Simmons SJ Tjoa BA Rogers M	1999	Prostate1999，39，4：	1
2	Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease显示文摘	Murphy GP Tjoa BA Simmons SJ		0，，：	1
3	GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial显示文摘	Tjoa BA Rogers M	1999	Prostate1999，39，4：	1
4	Evaluation of phase Ⅰ/Ⅱ clinical trials in prostate cancer with dendritic cells and PSMA peptides显示文摘	Tjoa BA Simmons SJ Bowes VA	1998	Prostate1998，36，1：	1
5	Follow-up evaluation of a phase Ⅱ prostate cancer vaccine trial 显示文摘	SIMMONS ST ELGAMAL AA	1999	Prostate1999，40，2：	1
6	Phase Ⅱprostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment 显示文摘	Murphy GP Tjoa BA Simmons S J	1999	Prostate1999，39，1：	1
7	Technoeconomic anal- ysis of a lignocellulosic ethanol biorefinery with ionic liq- uid pre-treatment显示文摘	Klein D Simmons BA Blanch HW	2011	Biofuels Bioproducts & Biorefining2011，2011，10：	1
8	Comparingthe recalcitrance of eucalyptus,pine,and switchgrass using ionic liquid and dilute acid pretreatments显示文摘	Li C L Sun L Simmons BA	2013	BioEnergy research2013，6，1：	1
9	Phase Ⅱ prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment 显示文摘	Murphy GP Tjoa BA Simmons SJ	1999	Prostate1999，39，1：	1
10	Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase Ⅱ prostate cancer vaccine trial involving patients with hormone refractory metastatic disease显示文摘	Murphy GP Tjoa BA Simmons SJ	1999	Prostate1999，38，1：	1
11	Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides显示文摘	Tjoa BA Simmons SJ Bowes VA	1998	Prostate1998，36，1：	1
12	GM - CSF as a systemic adjuvant in a phase Ⅱ prostate cancer vaccine trial 显示文摘	Simmons SJ Tjoa BA Rogers M	1999	Prostate1999，39，4：	1
13	Infusion of dendritic cell spulsed with HLA-A2-specific prostate-specific membrane antigen peptides:a phase Ⅱ prostate cancer vaccine trial disease显示文摘	Murphy GP Tjoa BA Simmons SJ	1999	Prostate1999，38，1：	1
14	Infusion of Dendritic cells pulsed with HLA-A2-specific membrane antigen peptides: A phase Ⅱ prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease 显示文摘	Tjoa BA Simmons SJ	1999	Prostate1999，38，：	1
15	Follow up evaluation of a phase Ⅱ prostate cancer vaccine trial 显示文摘	Tjoa BA Simmons SJ Elgamal A	1999	Prostate1999，40，2：	1
16	Higher dose and less frequent dendritic cell infusions with PSMA peptides in homone - refractory metastatic prostate cancer patients 显示文摘	MURPHY GP TJOA BA SIMMON SJ	2000	Prostate2000，43，1：	1
17	Evaluation of phaseⅠ/Ⅱclinical trials in prostate cancer with dendritic cells and PSMA peptides显示文摘	Tjoa BA Simmons SJ Bowes VA	1998	Prostate1998，36，1：	1
18	Infusion of dendriticcells pulsed with HLA-A2-specific prostate- specific membrane antigen peptides: a phaseⅡ prostate cancer vaccine trial involving patientswith hormone-refractory metastatic disease显示文摘	Murphy GP Tjoa BA Simmons SJ	1999	Prostate1999，38，1：	1
19	Infusion of dendritic cells pulsed with HLA-A2-speeific prostate-specific membrane antigen peptides: a phase Ⅱ prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease 显示文摘	Murphy GP Tjoa BA Simmons SJ	1999	Prostate1999，38，1：	1
20	Phase Ⅱ prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment 显示文摘	Murphy GP Tjoa BA Simmons SJ	1999	Prostate1999，39，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示